4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0000313143-13-000134
Options or other derivatives
- CFO & EVP Business Development acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LINDOP CHRISTOPHER J · CFO & EVP Business Development
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-07-24 | Grant or award : show line 1 in the form Performance Shares | +25,000 | $0.00 | 2017-12-31 | 25,000 | 25,000 | D |
Loading xslF345X03/edgardoc.xml…